Early Access Program of Lazertinib in Republic of Korea
Clinical trial NCT04829422 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04829422
- Sponsor
- Yuhan Corporation
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.